These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 8178162)
21. Immunology. New virtual center aims to speed AIDS vaccine progress. Cohen J Science; 2005 Jul; 309(5734):541. PubMed ID: 16040673 [No Abstract] [Full Text] [Related]
22. Neutralization of HIV-1. Golding H; D'Souza MP; Bradac J; Mathieson B; Fast P AIDS Res Hum Retroviruses; 1994 Jun; 10(6):633-43. PubMed ID: 8074927 [TBL] [Abstract][Full Text] [Related]
23. Dilemma of neutralization resistance of HIV-1 field isolates and vaccine development. Matthews TJ AIDS Res Hum Retroviruses; 1994 Jun; 10(6):631-2. PubMed ID: 8074926 [No Abstract] [Full Text] [Related]
24. Urgently needed: a filter for the HIV-1 vaccine pipeline. Moore JP; Burton DR Nat Med; 2004 Aug; 10(8):769-71. PubMed ID: 15286768 [TBL] [Abstract][Full Text] [Related]
25. Lobbying for an AIDS trial. Cohen J Science; 1992 Oct; 258(5082):536-9. PubMed ID: 1411563 [No Abstract] [Full Text] [Related]
26. Importance of neutralization sieve analyses when seeking correlates of HIV-1 vaccine efficacy. Montefiori DC Hum Vaccin Immunother; 2014; 10(8):2507-11. PubMed ID: 25424964 [TBL] [Abstract][Full Text] [Related]
28. A noninfectious simian/human immunodeficiency virus DNA vaccine that protects macaques against AIDS. Singh DK; Liu Z; Sheffer D; Mackay GA; Smith M; Dhillon S; Hegde R; Jia F; Adany I; Narayan O J Virol; 2005 Mar; 79(6):3419-28. PubMed ID: 15731236 [TBL] [Abstract][Full Text] [Related]
29. HIV vaccine research: the way forward. Fauci AS; Johnston MI; Dieffenbach CW; Burton DR; Hammer SM; Hoxie JA; Martin M; Overbaugh J; Watkins DI; Mahmoud A; Greene WC Science; 2008 Jul; 321(5888):530-2. PubMed ID: 18653883 [TBL] [Abstract][Full Text] [Related]
30. Scientific and policy challenges to development of an AIDS vaccine. Berkley SF; Koff WC Lancet; 2007 Jul; 370(9581):94-101. PubMed ID: 17617277 [No Abstract] [Full Text] [Related]
31. Did liability block AIDS trial? Cohen J Science; 1992 Jul; 257(5068):316-7. PubMed ID: 1631549 [No Abstract] [Full Text] [Related]
32. The next steps toward a global AIDS vaccine. Koff WC Science; 1994 Nov; 266(5189):1335-7. PubMed ID: 7973724 [No Abstract] [Full Text] [Related]
35. Candidate AIDS vaccines. Graham BS; Wright PF N Engl J Med; 1995 Nov; 333(20):1331-9. PubMed ID: 7566026 [No Abstract] [Full Text] [Related]
36. AIDS wins this round. Park A Time; 2007 Nov; 170(21):55. PubMed ID: 18074642 [No Abstract] [Full Text] [Related]
37. Results of the first phase 3 trial of an AIDS vaccine. Laurence J AIDS Read; 2003 Apr; 13(4):155-6. PubMed ID: 12741363 [No Abstract] [Full Text] [Related]
38. AIDS vaccine development. Agosto M; Allan J; Benson C; Berger EA; Blumenthal R; Burton D; Clements J; Coffin J; Connor R; Cullen B; Desrosiers R; Dimitrov D; Doms R; Emerman M; Feinberg M; Fultz P; Gerard C; Gonsalves G; Haase A; Haigwood N; Hirsch V; Ho D; Hoxie JA; Hu SL; Zingale D Science; 1998 May; 280(5365):803, 804-5. PubMed ID: 9599148 [No Abstract] [Full Text] [Related]
39. Measuring vaccine-induced HIV neutralization: report of a workshop. Hanson CV AIDS Res Hum Retroviruses; 1994 Jun; 10(6):645-8. PubMed ID: 8074928 [No Abstract] [Full Text] [Related]
40. The role of the SIV model in AIDS vaccine research. Friedrich TC; Watkins DI IAVI Rep; 2005; 9(2):1, 6-8. PubMed ID: 16156073 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]